Objective: It is aimed to evaluate contribution of two molecules of Caffeine salicylate, a combinatorial product, in the CNS stimulant, anti-inflammatory and an analgesic property in experimental animal models. Material and Methods: Caffeine salicylate is synthecised by one step reaction from caffeine and salicylic acid. Actophotometer and open field test were used for the CNS stimulant activity whereas formalin induced rat paw edema and tail immersion test were used to evaluate anti-inflammatory and analgesic properties in experimental animals. Results: The locomotor activity was increased from 37.1% for caffeine to 49.24% for caffeine salicylate. In open field test; number of crossing and rearing were increased from 42.34 % to 54.89% and 17.26% to 27.87% respectively. The % inhibition on rat paw edema 16.40% and 18.75% with caffeine salicylate as against diclofinac 51.0% and 62.5% at 60 and 120 min. respectively. The tail withdrawal time was prolonged by 25% with caffeine salicylate as against 78.88 % with pentazocine in wistar rats. The results of all experimental animal models were statistically significant. Conclusion: The enhancement in the cortical arousal by caffeine salicylate over caffeine may be due to contribution of antioxidant property of salicylate besides adenosine antagonism and mobilization of intracellular calcium induced dopamine release by caffeine portion of caffeine salicylate. The mild analgesic and anti-inflammatory activities of caffeine salicylate may be due to inhibition of prostaglandin synthesis and an antioxidant properties of salicylate portion of caffeine salicylate.
INTRODUCTION
Caffeine salicylate is a combinatorial product synthesized from equimolar concentration of caffeine and salicylic acid. The indirect CNS stimulant activity of caffeine is due to the antagonism of adenosine, mobilization of intracellular Ca 2+ influencing indirectly the release of dopamine, and inhibition of specific phosphodiesterase at high concentration. Where as salicylate acts by inhibition of synthesis of prostaglandin by inhibiting cycoloxygenase I and by direct activation of AMP activated protein kinase. It is planned in this paper to evaluate CNS stimulant properties of caffeine and mild analgesic and anti-inflammatory activities of salicylates individually and in the combinatorial product caffeine salicylate.
MATERIALS AND METHODS

Synthesis of Caffeine salicylate
5 g of caffeine and 3.57 g of salicylic acid was dissolved in 245 ml of dichloromethane. The reaction mixture was heated to boil followed by gentle boiling for about 5 minutes. The solution was cooled to room temperature. Petroleum ether was added drop wise until the mixture is turned to cloudy. The reaction mixture was cooled slowly to room temperature and then cooled it in ice. The traces of solvent were removed under vacuum. The weight of the product is 6.106 g i.e. 71% w/w.
1
Locomotor activity
Locomotor activity was performed using actophotometer according to the method of Dews.
2,3 Swiss albino male mice weighing between 18-22 g were divided in five groups of six animals each. Group I received normal saline (0.2 ml/20 g). Group II and III received caffeine (20 mg/kg, p.o.) and Group IV and Group V received caffeine salicylate (34 mg/kg, p.o.). After 30 minutes animals were placed individually in the actophotometer. The movement of animal in terms of series of ambulation that leads to interruptions in the horizontal beam which were recorded as digital counts.
Open Field test
Open field test was performed according to method described by Hall and Ballachy, 4 Walsh et.al., 5 and Brown et.al. 6 The wistar albino male rats weighing 154-168 gm were divided in three groups of six animals each. Group I received 0.9% w/v NaCl (0.2 ml/20 gm 
Anti-inflammatory activity
Anti-inflammatory activity was performed using method of formalin induced rat paw edema described by Turner 7 Lee and Crosby 8 with suitable medications. Digital water pleythesmometer (Orchid, Nasik) is used to measure small volume changes. The water displacement produced by the immersion of rat paw in the measuring tube of the volume transducer which measures the displacement up to 0.01 ml resolution. The wistar male albino rats of weight range 200-250 g were divided into three groups of six animals each. Group I received normal saline (2 ml/200 g, p.o.), Group II received standard drug diclofinac (0.9 mg/100 g, s.c.) and group III received caffeine salicylate (6.1 mg/100 g, p.o.). Formalin (0.1 ml of 1%w/v) was injected in the planter region of left paw 30 minutes after the administration of normal saline, diclofinac and caffeine salicylate. The right paws being used as an uninflammed control. The difference in the mean volume between left and right paw is taken as paw volume. Anti-inflammatory activity as % inhibition in paw volume is calculated as % inhibition = [1-(Vt-Vo (treated) / Vt-Vo (control)] X 100.
Analgesic activity
Analgesic activity was performed using tail immersion test according to the method described by Ben Basset et.al. 9 , Gawade.
10 Male albino rats of weight range 200-225 g were divided into three groups of six animals each. Group I received normal saline (2 ml/200 g, p.o), Group II received pentazocine (20 mg/kg, p.o) and Group III received caffeine salicylate (34 mg/kg, p.o). The temperature of was maintained at 58 + 1 0 C. The tail of the animal was immersed individually and pain threshold response "tail withdrawal" in seconds with cut off time 10 seconds.
Experimental animals
Wistar rats and Swiss mice used in the present study, were housed and maintained under standard laboratory conditions in animals house registered by CPCSEA (1314/ac/09/CPCSEA) and were fed with standard pellet diet and water ad libitum. The protocol on experimental animal models were approved by Institutional Animal Ethical Committee.
Statistical analysis
The data was presented as Mean + S.E.M. (n=6). One way ANOVA with post hoc Dunnett test repeated measures ANOVA and paired 't' test were used to determine 'p' values using Graph pad Prism software (version 5). p<0.05 is considered as statistically significant.
RESULTS
Caffeine salicylate was synthecised from caffeine and salicylic acid. The % yield of caffeine salicylate is 71.6% w/w. Caffeine salicylate was characterized for melting point, Rf value on thin layer chromatography and UV spectral analysis for absorbance maximum and wave length. The results of chemical characterization were summarized in Table 1 . LD 50 of caffeine salicylate by oral route using OECD guidelines 423 was found to be 500 mg/kg. The locomotor activity was increased from 302.33 to 480.67*** (37.17%) for caffeine. The locomotor activity in caffeine salicylate injected mice was significantly higher than that of caffeine. It was increased from 267.67 to 527.33** (49.24%). The results of locomotor activity were summarized in Table 2 .
The additional locomotor activity was evaluated from parameters line crossing and rearing, using open field test in rats. The number of line crossing were increased from 50.0 + 2.24 to 71.17 + 3.83 (42.34%) in animals treated with caffeine. The number of line crossing was higher than that of caffeine in animals treated with caf- Table 3 and were found to be statistically significant. The number of rearing were increased from 149.67 + 3.1 to 175.5 + 3.68 (17.26%) in caffeine treated animals.
The number of rearing was higher than that of caffeine. It was increased from 149.5 + 2.6 to 191.17 + 3.07 (27.87%) in animals treated with caffeine salicylate. The results of caffeine salicylate using control and standard drug were summarised in Table 4 and were found to be statistically significant. Values are given as M ± SEM (n=6), paired 't' test *p<0.05,**p<0.01,***p<0.001.
The anti-inflammatory effects of caffeine salicylate were evaluated in comparison with standard anti-inflammatory drug, diclofinac on formalin induced rat paw edema. The time dependent enhancement in the antiinflammatory activity was revealed from increase in the % inhibition of inflammation with standard diclofinac 51.0% and 62.5% and with caffeine salicylate 16.4% and 18.75% at 60 min. and 120 min. respectively. The results were summarized in Table 5 . The analgesic effects of caffeine salicylate were evaluated using tail immersion heat conduction method in rats in comparison with standard, Pentazocine. The prolongation in tail withdrawal time from warm water is used as a measure of analgesic activity. The tail withdrawal time was prolonged from 1.61 + 0.096 to 2.88 + 0.14*** sec. (78.88%) with standard pentazocine.
Whereas it was prolonged from 1.64 + 0.11 to 2.05 + 0.12*** sec. (25.00%) in caffeine salicylate treated rats. The results were summarized in Table 6 .
DISCUSSION
In the present communication CNS stimulant, analgesic and antinflammatory property of caffeine salicylate and vis a vis contribution of two molecules caffeine and salicylic acid in these activities in a combinatorial product is evaluated using four independent standard methods in experimental animal models. The locomotor and exploratory activity was significantly higher in animals injected with caffeine salicylate as compared to caffeine revealing enhancement in the profound CNS stimulant action of caffeine salicylate. The anti-inflammatory action of sodium salicylate has been reported in the rat. 11 The mild analgesic activity as shown in tail immersion test in rats may be due to inhibition of synthesis of prostanoid from arachiodonic acid by salicylate component of caffeine salicylate. The mild anti-inflammatory activity of caffeine salicylate may be due to an antioxidant and adenosine release property of salicylate component of caffeine salicylate.
12-14 The CNS stimulation caused by caffeine is indirectly via behavioral arousal. Caffeine by binding to adenosine prevents it from acting on adenosine A 2A receptor to induce inhibitory depressive state. 15, 16 Adenosine is an inhibitory modulator for neuronal excitability, reduce arousal, induce sleep, and suppress spontaneous activity. The antioxidant property of salicylate reduces extracellular level of adenosine. Depression is often associated with calming effect, 
CONCLUSION
In conclusion caffeine salicylate is synthesized from caffeine and salicylic acid in equimolar proportion by a single step reaction. It is a chance observation that CNS stimulant activity of caffeine salicylate is significantly enhanced than that of caffeine. Besides salicylate component of caffeine salicylate contribute to the additional mild anti-inflammatory and analgesic activity.
